Detailed explanation of contraindications and precautions when using venetoclax

Venetoclax (Venclexta), also known as venetoclax, is a targeted treatment drug for chronic lymphocytic leukemia with significant efficacy. However, like all drugs, venetoclax must be used strictly according to medical instructions and a series of contraindications and precautions should be paid attention to to ensure the safety and effectiveness of the treatment.

Patients who are allergic to the components of venetoclax are strictly prohibited from using this drug. Before taking the medicine, the patient must ask the pharmacist about all the ingredients of the medicine to avoid the occurrence of allergic reactions. In addition, venetoclax interacts with certain drugs. Therefore, before taking it, patients need to inform their medical staff in detail about all the drugs they are taking, including prescription drugs, over-the-counter drugs, vitamins, minerals, herbal products, etc., so that doctors can evaluate the risk of drug interactions.

Patients should not self-administer venetoclax unless prescribed by their treating physician. During the period of taking the medicine, the patient should strictly follow the dosage and medication time prescribed by the doctor and cannot change it at will. At the same time, venetoclax should be swallowed whole and should not be chewed, cut or crushed to avoid affecting the efficacy of the medicine. To reduce the risk of tumor lysis syndrome, patients should drink plenty of water, at least 6 to 8 glasses of water per day, starting two days before taking the drug for the first time and each time the dose is increased.

Venetoclax may affect a patient's coordination, so patients should avoid driving or other activities that require a high degree of coordination until they know how the drug affects them. Patients are also asked to tell healthcare providers about any medical conditions they have, especially kidney or liver problems, abnormal electrolyte levels, a history of gout, and pregnancy or breastfeeding.

It is particularly noteworthy that venetoclax may cause harm to an unborn baby, so women of childbearing age should use effective contraceptive measures during treatment and for at least30 days after stopping the drug. Additionally, because it is not known whether venetoclax passes into breast milk, breastfeeding is not recommended while taking the drug and for at least one week after stopping the drug.

When it comes to vaccinations, patients should discuss with their healthcare provider which vaccines may be needed and avoid certain vaccines before and after using venetoclax to ensure the safety and effectiveness of treatment.

In short, when using venetoclax (venetoclax), you must strictly follow the doctor's instructions and pay attention to the contraindications and precautions to ensure the safety and effectiveness of the treatment. Patients should maintain close communication with medical staff and promptly report any abnormal symptoms or drug reactions so that doctors can adjust treatment plans in a timely manner.

References:

https://www.webmd.com/drugs/2/drug-171573/venclexta-oral/details